Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients (Q46228204)

20 December 2017

title

Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients (English)

1 reference

20 December 2017

chronic renal insufficiency

1 reference

1 reference

Alberto Ortiz

6

0 references

author name string

Ana M Ramos

1

1 reference

20 December 2017

Marta Albalate

2

1 reference

20 December 2017

Silvia Vázquez

3

1 reference

20 December 2017

Carlos Caramelo

4

1 reference

20 December 2017

Jesús Egido

5

1 reference

20 December 2017

publication date

1 December 2008

1 reference

20 December 2017

Kidney International. Supplement

published in

1 reference

20 December 2017

issue

111

1 reference

20 December 2017

page(s)

S88-93

1 reference

20 December 2017

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Vascular calcification and renal osteodystrophy relationship in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Pitfalls of measuring total blood calcium in patients with CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Relationship of phosphorus and calcium-phosphorus product with mortality in CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Nonphosphate-binding effects of sevelamer--are they of clinical relevance?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

J-shaped mortality relationship for uric acid in CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Differential effects of vitamin D analogs on vascular calcification

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.543

7 January 2021

Identifiers

DOI

10.1038/KI.2008.543

0 references

1 reference

20 December 2017